204
Aligos Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
134
FY23:
141
FY24:
62.1
FY25:
82.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
30.9
FY22:
13.1
FY23:
10.4
FY24:
7.95
FY25:
5.67
Total assets
Change from FY21 to FY25
millions USD
FY21:
235
FY22:
147
FY23:
152
FY24:
70.1
FY25:
88.5
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
39.0
FY22:
33.1
FY23:
23.9
FY24:
21.7
FY25:
21.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.7
FY22:
9.66
FY23:
35.5
FY24:
77.3
FY25:
13.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
185
FY22:
104
FY23:
92.1
FY24:
−29.0
FY25:
53.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
235
FY22:
147
FY23:
152
FY24:
70.1
FY25:
88.5
All amounts in millions USD